SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-013839
Filing Date
2020-03-30
Accepted
2020-03-30 07:05:49
Documents
4
Period of Report
2020-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 NANOTX OXFORD pstv-8k_20200329.htm 8-K 36653
2 EX-10.1 pstv-ex101_34.htm EX-10.1 340347
3 EX-10.2 pstv-ex102_8.htm EX-10.2 409153
4 EX-99.1 pstv-ex991_6.htm EX-99.1 21298
  Complete submission text file 0001564590-20-013839.txt   808888
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

IRS No.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 20753972
SIC: 3841 Surgical & Medical Instruments & Apparatus